Trikafta 100-50-75 MG/75MG PKT 14S
Ended Awarded
- Contract number
- SPE2DB25FZQ08
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $112,587
Award facts
- Contract value 100% obligated
- $112,587.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $112,587.38 by the Defense Logistics Agency on September 2, 2025, with an ultimate completion date of September 3, 2025. The contract covers the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14, a prescription medication used in the treatment of cystic fibrosis. This delivery order was issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain.
This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated consistent success in competing for federal pharmaceutical contracts, leveraging its woman-owned small business status to secure a robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables for military health systems.
Quick answers
Who was awarded contract SPE2DB25FZQ08?
SPE2DB25FZQ08 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FZQ08 worth?
The government has obligated $112,587 on SPE2DB25FZQ08.
Is contract SPE2DB25FZQ08 an order under another contract?
Yes. SPE2DB25FZQ08 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB25FZQ08 competed?
The extent of competition for SPE2DB25FZQ08 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award